ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) shares shot up 0.8% during mid-day trading on Monday . The stock traded as high as C$6.70 and last traded at C$6.50. 19,980 shares were traded during trading, an increase of 3% from the average session volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Price Performance
The firm has a 50 day moving average of C$6.50 and a 200-day moving average of C$6.50. The company has a market cap of C$162.08 million and a P/E ratio of -7.30. The company has a current ratio of 5.06, a quick ratio of 4.29 and a debt-to-equity ratio of 1.70.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- 3 Small Caps With Big Return Potential
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- 3 REITs to Buy and Hold for the Long Term
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How is Compound Interest Calculated?
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
